AFP - New blood pressure drug has fewer side effects: study
CHICAGO (AFP) — A new drug for treating high blood pressure, telmisartan, is as effective as the popular drug ramipril but with fewer side effects, according to a study published Monday.
After four and a half years of study, researchers found that temisartan (marketed as Micardis, Pritor or Kinzal) and ramipril (Tritace, Ramace or Altace) were equally effective in reducing the rate of deaths from heart disease and strokes, said researchers presenting their conclusions at the 57th annual meeting of the American College of Cardiology in Chicago.
Related Results
Research and Markets: Benchmark Abbotts Performance Against Key Rivals In The…
Drug challenge
JAPANESE NEWSPAPER HIGHLIGHTS - AUG 23, 2004.
Hypertensive drug classes: brand names only
Combination hypertension drug approved
“If it’s possible to have access to a medication that can prevent serious cardiovasular events but with fewer side effects and better compliance than what’s currently available, it will also have a great impact on their quality of life,” said Gilles Dagnesais, one of the study’s coordinators.
Some 25,620 patients at least 55 years old and suffering from coronary problems …
Read the full article with a Free Trial at MyWire.
